MLYS - Mineralys Therapeutics, Inc.
27.51
-0.980 -3.562%
Share volume: 603,761
Last Updated: 04-24-2026
Pharmaceutical Products/Pharmaceutical Preparations:
-0.11%
PREVIOUS CLOSE
CHG
CHG%
$28.49
-0.98
-0.03%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-09-2024 | 08-13-2024 | 11-12-2024 | 02-12-2025 | 05-12-2025 | 11-10-2025 | 03-12-2026 | |
| Cash flow financing | 116.205 M | -152.000 K | -1.000 K | 90.000 K | 189.279 M | 295.188 M | 96.701 M | |
| Other financing cash flows | 149.000 K | 54.000 K | 40.000 K | 54.000 K | 123.000 K | 6.624 M | 4.960 M | |
| Cash flow | 41.114 M | -22.562 M | 29.418 M | 16.817 M | 50.916 M | 115.809 M | -44.676 M | |
| Net income | -31.508 M | -41.014 M | -56.342 M | -48.946 M | -42.211 M | -36.932 M | -32.234 M | |
| Depreciation | 8.000 K | 9.000 K | 11.000 K | 15.000 K | 15.000 K | 15.000 K | 13.000 K | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | -55.952 M | 7.736 M | 79.605 M | 83.570 M | -92.876 M | -150.507 M | -103.489 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 59.000 K | 0.000 | 37.000 K | 0.000 | 0.000 | 0.000 | 15.000 K | |
| Cash Change | 41.114 M | -22.562 M | 29.418 M | 16.817 M | 50.916 M | 115.809 M | -44.676 M |